BioTuesdays

Category - Markets

Markets

HCW cuts Sesen Bio to neutral; withdraws PT

H.C. Wainwright downgraded Sesen Bio (NASDAQ:SESN) to “neutral” from “buy” and removed its price target after the company on Aug. 13 received a complete response letter from the FDA. The stock closed at $2.11 on Aug. 13...

August 16, 2021
RAPT-Therapeutics
Markets

SVB Leerink starts RAPT Therapeutics at OP; PT $49

SVB Leerink launched coverage of RAPT Therapeutics (NASDAQ:RAPT) with an “outperform” rating and a $49 price target. The stock closed at $33.07 on Aug. 11. RAPT is a clinical-stage biopharmaceutical company developing...

August 12, 2021
Sera Prognostics
Markets

WB starts Sera Prognostics at OP

William Blair launched coverage of Sera Prognostics (NASDAQ:SERA), a pregnancy diagnostics company, with an “outperform” rating. The stock closed at $12.85 on Aug. 6. Analyst Brian Weinstein writes that the current rate...

August 9, 2021
CTIBiopharmaLogo
Markets

BTIG starts CTI Biopharma at buy; PT $7

BTIG initiated coverage of CTI Biopharma (NASDAQ:CTIC) with a “buy” rating and price target of $7. The stock closed at $2.80 on Aug. 6. CTI is a biotechnology company engaged in the development of therapeutics for blood...

August 9, 2021
BeyondSpring Logo
Markets

HCW ups BeyondSpring to buy from neutral; PT $100

H.C. Wainwright upgraded BeyondSpring (NASDAQ:BYSI) to “buy” from “neutral” with a price target of $100 after the company reported positive topline results from its DUBLIN-3 registrational trial of plinabulin in...

August 4, 2021
Immutep Logo
Markets

Ladenburg starts Immutep at buy; PT $8.30

Ladenburg Thalmann launched coverage of Immutep of Australia (NASDAQ:IMMP) with a “buy” rating and $8.30. The stock closed at $3.46 0n Aug. 2. Immutep is a clinical-stage immuno-oncology company focused on developing...

August 3, 2021